Although tumor growth in murine lung cancer was significantly suppressed in VSIG4-deficiency mice and VSIG4 blockade showed anti-tumor activity in fibrosarcoma [13, 44], the exact role and mechanism of VSIG4+ TAMs in aggressive cancers remain unclear. This evidence concerns the gene VSIG4 and fibrosarcoma.